title: Irinotecan-induced interstitial pneumonia.
authors.affiliation: Multidisciplinary Oncology Center, University Hospital, Lausanne, Switzerland.
authors.forename: O
authors.initials: O
authors.lastname: Michielin
authors.forename: E
authors.initials: E
authors.lastname: Udry
authors.forename: D
authors.initials: D
authors.lastname: Périard
authors.forename: O
authors.initials: O
authors.lastname: Matzinger
authors.forename: J A
authors.initials: JA
authors.lastname: Lobrinus
authors.forename: R
authors.initials: R
authors.lastname: Stupp
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001932:Brain Neoplasms / Q000188:drug therapy*; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003937:Diagnosis, Differential; D005625:Frontal Lobe; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D000077146:Irinotecan; D017563:Lung Diseases, Interstitial / Q000139:chemically induced / Q000175:diagnosis* / Q000000981:diagnostic imaging; D008297:Male; D011859:Radiography; D000077204:Temozolomide
chemical_list: D000077146:Irinotecan; D003606:Dacarbazine; D002166:Camptothecin; D000077204:Temozolomide